RecallRadar

CPSC recall 22754

Lidocaine 4% Topical Anesthetic Cream

On 2022-06-30 the CPSC announced a recall of Lidocaine 4% Topical Anesthetic Cream by Mohnark Pharmaceuticals, citing the product contains lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging is not child resistant, posing a….

Read the official CPSC notice

AgencyCPSC
Recall number22754
ClassificationNot classified
Statusunknown
Initiated2022-06-30
Published2022-06-30
Last updated2026-09-13 11:58 UTC
CompanyMohnark Pharmaceuticals
DistributionUS

Product

Lidocaine 4% Topical Anesthetic Cream | The recall involves Mohnark Pharmaceuticals Lidocaine 4% Topical Anesthetic Cream. The product was sold in a white tube with a flip-top closure. Mohnark Pharmaceuticals is printed under the blue and green logo on the right side of the product tube. The lot code is located at the bottom of the product tube. The affected lot codes are 01202201, 210201, 210301, 210503, 210505, 210601, 211002 and 210401. The UPC 860002324906 is located on bottom side panel of the packaging.

Reason

The product contains lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging is not child resistant, posing a risk of poisoning to young children if they ingest the anesthetic cream.

Identifiers

upc860002324906

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:58 UTC. Current status: unknown.

Source

Official record: https://www.cpsc.gov/Recalls/2022/Mohnark-Pharmaceuticals-Recalls-Lidocaine-Topical-Anesthetic-Cream-Due-to-Failure-to-Meet-Child-Resistant-Packaging-Requirement-Risk-of-Poisoning-Recall-Alert

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.